World of DTC Marketing

AUGUST 21, 2020

As the NY Times recently reported , obesity is the leading cause of mortality in the United States. Obesity costs the nation $1.72 trillion every year. In the United States, where at least 4.6 And it’s getting worse.

Insurance 238

Insurance Physicians Healthcare Healthcare 238

World of DTC Marketing

AUGUST 22, 2022

Globally, nearly half of deaths due to cancer can be attributable to preventable risk factors, including three leading risks of smoking, drinking too much alcohol, or having a high body mass index, a new paper suggests. on cancer-related health care in 2015, and this amount is projected to grow to $246 billion by 2030—an increase of 34%.

Food 229

Food Education Government Patients 229

pharmaphorum

JULY 8, 2022

The number of AI-based drug discovery strategic alliances has increased significantly, from just 10 in 2015 to 105 in 2021, with companies like BenevolentAI, Exscientia and Insilico Medicine featuring prominently in the dealmaking. billion, according to the report.

Marketing 122

Marketing Pharma Education Medicine 122

pharmaphorum

OCTOBER 31, 2022

The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen. Alice Zhang.

Pharma 124

Pharma Leads Medicine Marketing 124

pharmaphorum

NOVEMBER 11, 2022

According to court documents, Cohen reached out in 2015 to Moshe Alafi, former general partner at Alafi Capital who he had known for decades – and his son Christopher Alafi, who is the firm’s capital director – to seek investment in Nuredis. ” pharmaphorum has contacted Dr Cohen for comment on the case.

Leads 85

Leads FDA Marketing 85

European Pharmaceutical Review

JULY 7, 2022

He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.

Medical 90

Medical Medicine Pharmaceutical Training 90

European Pharmaceutical Review

AUGUST 8, 2022

Dan Miller of Walden Macht & Haran, lead counsel to Streck, commented on the decision: “The jury has spoken. million) in 2015 , also for knowingly underpaying Medicaid rebates. Eli Lilly knowingly violated the False Claims Act and defrauded the Medicaid Program of $61 million in taxpayer money. . million) and Cephalon ($7.5

Manufacturing 90

Manufacturing Pharmaceutical Pharma Leads 90

Pharmaceutical Technology

DECEMBER 6, 2022

The three leading Alzheimer’s disease (AD) drugs currently in development are all monoclonal antibodies—donanemab by Eli Lilly , lecanemab by Eisai and Biogen , and gantenerumab by Roche. AD currently affects more than 55 million people worldwide. Monoclonal antibodies make up half of these, with an 11% share of all AD approvals.

Marketing 59

Marketing Leads Pharmaceutical FDA 59

European Pharmaceutical Review

APRIL 27, 2023

His contributions “have been integral in the evolution of our portfolio over the past several years, notably building our leading presence in immuno-oncology, growing our CV business and launching multiple new medicines,” Samuels added. Theodore R Samuels will continue to serve as Lead Independent Director.

Medicine 72

Medicine Marketing Government Leads 72

European Pharmaceutical Review

JUNE 30, 2023

Since the 1990s, the annual harvest of Chinese horseshoe crab ( Tachypleus tridentatus ) for biomedical purposes has dropped from 600,000 to 100,000 in 2015, the paper noted. This conservation leads to a greater usage efficiency of the volume of reagent.

Manufacturing 88

Manufacturing Pharmaceutical Prospecting Leads 88

World of DTC Marketing

MARCH 19, 2021

In actual numbers, in 2015, poor diet was associated with over 52,200 colorectal cancer cases; over 14,400 mouth, pharynx and larynx cancers ; nearly 3,200 uterine cancers ; just over 3,000 cases of breast cancer in postmenopausal women; 2,000 kidney cancers ; nearly 1,600 stomach cancers ; and 1,000 liver cancers.

Healthcare 143

Healthcare Healthcare Side effects Medical 143

pharmaphorum

JANUARY 9, 2023

is to acquire the 2015-established Amryt Pharma Plc. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Biopharma and healthcare group Chiesi Farmaceutici S.p.A. on 6 th January.

Pharma 80

Pharma Biopharma Medicine Management 80

pharmaphorum

OCTOBER 28, 2022

Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England. Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. She is an SME in market access, rare disease and biosimilars.

Medicine 108

Medicine Management Marketing Leads 108

European Pharmaceutical Review

JANUARY 24, 2023

She was medical lead at SIBAmed GmbH for four years. At Parexel, Sandra held roles in Phase I project management and business development, before being promoted to a senior portfolio director in 2015. There, she oversaw clinical trials, including coordination, execution and regulatory processes.

Key account management 95

Key account management Physicians Networking Management 95

European Pharmaceutical Review

MARCH 11, 2024

In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. World Health Organization. The Global Health Observatory.

Medicine 92

Medicine Pharmacology Healthcare Healthcare 92

pharmaphorum

AUGUST 23, 2022

It isn’t the first dengue vaccine to reach the market, but is free of the severe restrictions that have held back its only predecessor, Sanofi’s Dengvaxia , which was cleared for marketing in 2015. Dengue fever is unusual in that a first infection is rarely serious, but a second can lead to much more serious disease.

Marketing 93

Marketing Food FDA Leads 93

InCrowd

DECEMBER 14, 2022

My team and I highlight customer value, drive lead generation, support sales, and stimulate client utilization of both commercial solutions, as well as demonstrate InCrowd and SHG’s combined value through Apollo Advantage initiatives. I joined in 2015 and have never looked back.

Marketing 59

Marketing Pharma Sales Healthcare 59

European Pharmaceutical Review

AUGUST 26, 2022

Moderna claims that, when COVID-19 emerged, neither company had the same level of experience with “developing mRNA vaccines for infectious diseases” as Moderna, adding: “they knowingly followed Moderna’s lead in developing their own vaccine.”. ” But why sue now?

Sales 90

Sales Medicine Marketing Government 90

pharmaphorum

OCTOBER 29, 2015

Findings from the Veeva 2015 European Life Sciences Survey Is the industry getting what it needs? Customer data challenges are among the most vexing and pervasive that life sciences companies currently experience, especially with the increasing regulatory pressure and the transition to new business models they face.

Leads 52

Leads Marketing Pharma 52

European Pharmaceutical Review

OCTOBER 7, 2022

In the years 2015 and 2020, clinical-stage cancer programmes increased by a considerable 77 percent (1,642 to 2,911), resulting in a quarter of drugs currently in development worldwide being highly potent. Leading companies in the oral solid dosage market are Catalent, Inc.,

Manufacturing 86

Manufacturing Marketing Side effects Transportation 86

Legacy MEDSearch

AUGUST 8, 2022

was established in China in 2015 and is a subsidiary of MicroPort Scientific Corporation. About MicroPort NaviBot MicroPort NaviBot International LLC was incorporated in 2020 and is headquartered in Foxborough, MA. NaviBot is subsidiary of MicroPort MedBot. About MicroPort MedBot Shanghai MicroPort MedBot (Group) Co.,

Food and Drug Administration 98

Food and Drug Administration Recruitment Medical Food 98

pharmaphorum

SEPTEMBER 1, 2022

She was also a founder and chief scientific officer of UK biotech Heptares Therapeutics, maintaining that role after it was acquired by Japan’s Sosei in 2015, and held previous roles at Cambridge University, Millennium Pharma, and GSK. " This rings true today as I share news that I will step down as President of NIBR on Oct 31. .

Medicine 59

Medicine Biopharma Engineering Pharma 59

pharmaphorum

OCTOBER 7, 2022

BenevolentAI is a leading clinical-stage AI drug discovery company. The number of AI-based drug discovery strategic alliances has increased significantly in recent years: There were just 10 in 2015; in 2021, there were 105. By combining the power of AI with human expertise we are bringing new drug targets into our portfolio.”.

Sales 83

Sales Leads 83

Spotio

MAY 10, 2023

Business-to-business (B2B) prospecting is the pillar of lead generation. According to Technology Advice , 70% of marketers at B2B companies reported that “improving lead quality” was the primary concern. Also, 54%said getting more leads was a top objective as well. Also, 54%said getting more leads was a top objective as well.

B2B Sales 98

B2B Sales Prospecting Sales CRM 98

European Pharmaceutical Review

APRIL 11, 2024

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. He leads Siemens’ efforts to optimise and improve processes for clients within the pharmaceutical, biopharmaceutical and medical device sectors. References Belkhir L, Elmeligi A.

Manufacturing 96

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 96

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. That same report noted that the number of companies in the AI drug discovery space increased tenfold between 2015 and 2021.

Medicine 74

Medicine Pharma Engineering Sales 74

pharmaphorum

OCTOBER 7, 2022

IQVIA has the long term market data, from World Reviews back to 1978, to investigate, and analysed nearly 30 years of launches into leading therapy classes, from multiple eras in the development of the pharmaceutical industry. Is this true?

Competition 70

Competition Marketing Medicine Pharmaceutical 70

PM360

JULY 18, 2022

FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore.

Biopharma 96

Biopharma Management Leads Marketing 96

Eversana Intouch

OCTOBER 13, 2023

10 The more than 350 program initiatives address economic stability, education access/quality, health care access/quality, neighborhood/built environment and social/community context, 2 and focus on 23 high-priority leading health indicators (LHIs) that impact major causes of death and disease in the United States. August 2015.

Pharma 87

Pharma Education Government Pharmaceutical 87

pharmaphorum

DECEMBER 6, 2022

The debit facility is being provided by Summit’s co-chief executives Bob Duggan and Maky Zanganeh, both veterans of Pharmacyclics who pocketed rich rewards when the company was sold to AbbVie for $21 billion in 2015.

Patients 52

Patients Pharma Leads Marketing 52

pharmaphorum

SEPTEMBER 16, 2022

The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. Next, they need experiential evidence that will support progressing these revealed prioritised targets into the discovery of lead molecules. Technological breakthroughs in molecular biology.

Leads 120

Leads Patients Medicine FDA 120

pharmaphorum

OCTOBER 12, 2022

The research collaboration will explore the use of the two companies’ technologies side by side to find targets across a range of human diseases for an initial six-month period, and if successful could lead to a long term, strategic level partnership, according to the partners.

Pharma 64

Pharma Training Networking Leads 64

Clarivate

DECEMBER 8, 2021

Starting with 12,147 Research Fronts, representing papers published and cited between 2015 and 2020, the next step was to select the fronts containing core literature that is both highly cited and recent – a measure of particularly active and fast-moving research.

Specialization 98

Specialization Leads Government Medical 98

pharmaphorum

NOVEMBER 6, 2017

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system.

Medicine 52

Medicine Pharma Patients Leads 52

World of DTC Marketing

JUNE 4, 2021

Mike always battled weight issues, but since he went out on disability, he had gained more weight, leading to diabetes. An unhealthy diet is one of the leading risk factors for poor health and accounts for up to 45% of all deaths from these cardiometabolic diseases, the researchers noted. 1ne: We eat out — a lot.

Food 207

Food Insurance Leads Medical 207

pharmaphorum

JULY 15, 2022

Teva launched its first generic in that year with a skinny label that excluded the heart failure use, as it was covered by a use patent that expired in 2015. The substance patent expired in 2007.

Prescription 52

Prescription Government Doctors Marketing 52

Impetus Digital

MARCH 15, 2024

As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers (2). Compared to 2015, the proportion of the world’s population aged > 60 years is estimated to increase by nearly 50% by 2050 (5).

Recruitment 94

Recruitment Healthcare Provider Patients Healthcare 94